Antibiotic resistance in neonates in China 2012–2019: A multicenter study

Antibiotic resistance in neonates in China 2012–2019: A multicenter study

Background: To investigate antibiotic resistance of pathogens responsible for neonatal invasive bacterial infections (IBIs) in China. Methods: Cross-sectional study of neonates with IBI evaluated in nine hospitals in China (January 2012–August 2019). Antibiotic resistance patterns of pathogens respo...

Full description

Bibliographic Details
Main Authors: Chen, C. (Author), Gong, X. (Author), Lei, X. (Author), Li, J. (Author), Shan, L. (Author), Tan, J. (Author), Wang, Y. (Author), Zhang, Q. (Author), Zhang, Y. (Author), Zhao, Y. (Author), Zhong, W. (Author), Zhou, Q. (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2022
Subjects:
ampicillin
Ampicillin
Anti-Bacterial Agents
antibiotic resistance
Antibiotic resistance
antiinfective agent
cefotaxime
Cefotaxime
ceftriaxone
Ceftriaxone
China
clindamycin
Clindamycin
clinical trial
Cross-Sectional Studies
cross-sectional study
Drug Resistance, Bacterial
Drug Resistance, Microbial
epidemiology
erythromycin
Erythromycin
Escherichia coli
human
Humans
Infant, Newborn
Invasive bacterial infections(IBIs)
microbial sensitivity test
Microbial Sensitivity Tests
multicenter study
Neonate
newborn
penicillin derivative
Penicillins
Staphylococcus aureus
Streptococcus agalactiae
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items